Detalhe da pesquisa
1.
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
J Antimicrob Chemother
; 68(6): 1400-5, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23404192
2.
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
J Antimicrob Chemother
; 68(11): 2626-31, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23798669
3.
Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy.
Antimicrob Agents Chemother
; 54(11): 4910-3, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20713677
4.
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
J Antimicrob Chemother
; 65(12): 2620-7, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20965891
5.
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks.
PLoS One
; 7(7): e41390, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22848481
6.
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
PLoS One
; 6(6): e20967, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21738597
7.
Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.
AIDS
; 24(15): 2365-74, 2010 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20802297